Stocks › KMDA
Kamada Ltd. (KMDA) stock analysis
WEAK BUY 31% confidence · analysed Aug 26, 2026
This analysis is from Aug 26, 2026 and may be out of date.
On Aug 26, 2026, our model rated Kamada Ltd. (KMDA) WEAK BUY with 31% confidence at a price of $8.54. That means the signals lean positive, but they are mixed, so conviction is low.
Technical picture
The 14-day RSI is 81, above 70, which is overbought: buyers have been very aggressive and a pause or pullback is common from here.
MACD is above its signal line, a sign that short-term momentum is turning up.
The price is above both its 50-day and 200-day moving averages, the classic picture of an uptrend.
Volume is only 0.6x its 20-day average; light trading makes the latest move less convincing.
Trend structure and money flow
Market structure: ranging / no clear structure.
The most recent swing high is $9.08 and the swing low is $6.31; traders often treat these as resistance and support.
Fundamentals
The PEG ratio is 0.66, which looks cheap relative to its expected growth.
The company reports a profit margin of 11.6% and revenue growth of +22.7%.
In its latest quarter it earned $0.16 per share, which beat the $0.11 analysts expected, with revenue +2.8% year over year.
Wall Street's average rating is 1.0 on a 1 (strong buy) to 5 (sell) scale, roughly a "strong buy", with an average price target of $13.50.
The next earnings report is expected around Nov 9, 2026; prices often move sharply around earnings.
Trade plan from the model
The model's long / bullish plan uses an entry near $8.45, a target of $9.09 (+7.6%) and a stop-loss at $7.92 (-6.3%).
That is a reward-to-risk ratio of about 1.2 to 1: the potential gain is not much bigger than the loss, so the setup is marginal.
The plan has a time limit: reassess by Sep 5, 2026 whatever the price does.
The model's one-paragraph read
Leans BUY — composite score +0.31 (WEAK BUY). Technicals: RSI 80.61, MACD bullish, price above SMA50. Fundamentals: PEG 0.66, margin 11.6%, revenue growth 22.7%. Financial results: YoY revenue +2.8%, last EPS surprise +45.5%, next earnings 2026-11-09. Smart Money Concepts: ranging / no clear structure. FinGPT news read: positive. Suggested levels: entry $8.45, target $9.09, stop-loss $7.92, exit by 2026-09-05 (10-calendar-day max hold (time-stop; reassess by this date regardless of P&L)).
Past ratings for KMDA
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Aug 26, 2026 | WEAK BUY | 31% | $8.54 | — |
"Move since" compares each call's price with the latest analysed price.
Other Healthcare stocks we cover
LH · LLY · MDT · NRC · NVO · OSCR · PCRX · PGNY · PHR · PRGO · SDZNY · SNN
Frequently asked questions
Is KMDA a buy right now?
As of Aug 26, 2026, our automated model rates Kamada Ltd. (KMDA) WEAK BUY with 31% confidence: the signals lean positive, but they are mixed, so conviction is low. This is a model output for education, not personal investment advice.
What is the price target for KMDA?
The model's most recent plan targets $9.09 with a stop-loss at $7.92, from an entry near $8.45.
When does Kamada Ltd. report earnings next?
The next earnings report is expected around Nov 9, 2026.
What does a WEAK BUY rating mean?
A WEAK BUY rating means the signals lean positive, but they are mixed, so conviction is low.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.